Tribunal upholds revenue's transfer pricing adjustments, comparables inclusion, reimbursable expenses treatment, and bonus disallowance.

The Tribunal dismissed all grounds of the assessee's appeal, upholding the revenue authorities' determinations on transfer pricing adjustments, inclusion of comparables, treatment of reimbursable expenses, non-allowance of +/-5% benefit, and disallowance of bonus to shareholder-directors. The appeal was dismissed in its entirety.

---

---

Issues Involved:

1. Determination of Arm's Length Price (ALP) using single year data.
2. Inclusion of two new companies as comparables.
3. Sustaining the selection of Khandwala Securities Ltd. as a comparable.
4. Treatment of reimbursable expenses and corresponding reimbursements.
5. Non-allowance of +/-5% benefit under proviso to section 92C(2).
6. Disallowance of bonus paid to shareholder-directors under section 36(1)(ii).

Issue-wise Detailed Analysis:

1. Determination of Arm's Length Price (ALP) using single year data:

The assessee argued that the revenue authorities should consider data from two prior financial years (2005-06 and 2006-07) along with the current year (2007-08) to determine the ALP. However, it was held that, as per Rule 10B(4) of the Income-tax Rules, 1962, the data relating to the financial year in which the international transaction was entered into should be used. The Tribunal found no abnormal or exceptional circumstances that would necessitate using multi-year data, thus dismissing this ground of appeal.

2. Inclusion of two new companies as comparables:

The assessee contested the inclusion of Brescon Corporate Advisors Ltd. and Keynote Corporate Services Ltd. as comparables, arguing that their high profits should exclude them. However, the Tribunal ruled that high profits alone do not justify exclusion under Rule 10B(2) or 10B(3). The decisive factors are the specific characteristics of services, assets, risks, and market conditions, not profit levels. Thus, this ground of appeal was dismissed.

3. Sustaining the selection of Khandwala Securities Ltd. as a comparable:

The assessee objected to Khandwala Securities Ltd. being a comparable due to its exceptional profits. The Tribunal reiterated that high or low profits are not determinative factors for exclusion under Rule 10B. The inclusion or exclusion depends on service characteristics, assets, risks, and market conditions. As the high profits were not due to factors specified in Rule 10B, this ground of appeal was also dismissed.

4. Treatment of reimbursable expenses and corresponding reimbursements:

The assessee argued that reimbursable expenses and corresponding reimbursements should not be considered part of operating expenses and income. The Tribunal found that these expenses were incurred in the course of providing services and were stipulated in the agreement with the AEs. Thus, they should be included in the cost base and operating income. This ground of appeal was dismissed.

5. Non-allowance of +/-5% benefit under proviso to section 92C(2):

The Tribunal held that the amendment made by the Finance Act, 2012, clarified that the +/-5% benefit under proviso to section 92C(2) is not a standard deduction but a tolerance range. The benefit is available only if the price of the international transaction is within this range of the ALP. As the assessee's price was not within this range, this ground of appeal was dismissed.

6. Disallowance of bonus paid to shareholder-directors under section 36(1)(ii):

The assessee challenged the disallowance of bonus paid to its shareholder-directors. The Tribunal noted that the bonus was paid in the same ratio as the shareholding (2:1), indicating it could have been paid as a dividend. The Tribunal distinguished the facts from other cases cited by the assessee, noting that the bonus was directly related to shareholding and not as a reward for work. Thus, the disallowance under section 36(1)(ii) was upheld, and this ground of appeal was dismissed.

Conclusion:

The Tribunal dismissed all grounds of the assessee's appeal, upholding the revenue authorities' determinations on transfer pricing adjustments, inclusion of comparables, treatment of reimbursable expenses, non-allowance of +/-5% benefit, and disallowance of bonus to shareholder-directors. The appeal was dismissed in its entirety.

---